Press release
Worldwide Analysis on Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Strategies and Forecasts, 2019
Post-traumatic stress disorder (PTSD) is a psychological condition that occurs in individuals of any age and gender. Its symptoms can show up immediately after a traumatic experience or with the course of time. It is one of the most common psychological disorders, affecting about 8 mn adult Americans and an annual incidence rate of close to 3.5% across the globe. Its first line of treatments includes counseling and psychotherapy. The population at risk includes veterans and soldiers. Some of the drugs that are usually prescribed are Zoloft by Pfizer, Elavil by AstraZeneca, and Paxil by GlaxoSmithKline.
Obtain Report Details @
http://www.transparencymarketresearch.com/post-traumatic-stress-disorder.html
The research report provides an in-depth analysis of the dynamics of the global PTSD therapeutics market and the extent to which they impact the growth of the market. It offers insights into the historical data and current scenario of the market to understand the growth rate of the market and also to make predictions about the future trends. For a coherent understanding, it segments the market on the basis of various criteria including treatment and geography. It presents invaluable information regarding the different parameters of the market that help new as well as existing players in making informed business decisions. It extensively covers the competitive landscape of the global PTSD therapeutics market.
Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market: Drivers and Restraints
The rising prevalence of PTSD is the primary factor driving the global PTSD therapeutics market. Globally, there are increasing cases of cross-border tensions and violence. To control such situations, military troops and police forces are deployed at sights of violence. This is leading to the development of PTSD among military personnel, which in turn is driving the demand for therapeutics for the treatment of this disorder. In addition, the increasing emphasis on rehabilitation programs for injured military personnel is working in favor of the growth of the market. Moreover, the growing number of road accidents, particularly in developing countries, is augmenting the market.
On the flip side, the serious side effects of certain drugs are leading to bad publicity and several lawsuits, which in turn is adversely affecting the growth of the market. Consumption of Zoloft and Paxil by pregnant women led to septal heart defects, miscarriage, delayed development, cranial defect, and persistent pulmonary hypertension (PPHN). However, the increasing research and development activities for understanding the mechanisms underlying PTSD is likely to pave way for new and safe therapeutics.
Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market: Geographical Segmentation
The key segments studied in the report on the basis of geography are Asia Pacific, Europe, North America, and Rest of the World. North America will be one of the major revenue contributors to the growth of the global market. The rising prevalence of PTSD is fuelling the demand for its therapeutics in the region. The presence of pharmaceutical giants along with the increasing research and development in the field is providing a fillip to the growth of the region. Asia Pacific will be a potential market owing to the high rate of motor accidents in high population countries.
Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market: Competitive Landscape
The global PTSD therapeutics market is characterized by high competitive rivalry. The market scenario is anticipated to change after the launch of novel therapies. Some of the prominent players in the market are GlaxoSmithKline, Pfizer, Neurocrine Biosciences, Novartis Pharmaceuticals, Azevan Pharmaceuticals, and Baylor Research Institute.
Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1950
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Worldwide Analysis on Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Strategies and Forecasts, 2019 here
News-ID: 706420 • Views: …
More Releases from Transparency Market Research
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035.
Gain a preview of important insights from…
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035.
Access key findings…
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)…
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035.
Access key…
More Releases for PTSD
Newmarket Therapist Expands Trauma and PTSD Recovery Programs
Silver Light Psychotherapy in Newmarket, led by Registered Psychotherapist (Qualifying) Erika Silveira, is expanding trauma and PTSD therapy services. With a trauma-informed, client-centered approach, the practice offers evidence-based support to help individuals process experiences, build resilience, and restore safety. In-person and virtual sessions plus free consultations ensure accessible care for clients across Ontario.
Newmarket, Ontario - Silver Light Psychotherapy, founded by Registered Psychotherapist (Qualifying) Erika Silveira, is expanding its services in…
Interactive Game Art "TUNE" Reveals Elephants' PTSD as War's Silent Victims
"Did I just kill that elephant? I just did what I normally do in games."
Image: https://www.globalnewslines.com/uploads/2025/09/e22fd917ec2fe862c3c4ee22520bf08a.jpg
This was the reaction of a visitor at the game art exhibition Tune, held from August 4 to 11 in Seongsu-dong, Seoul. The realization came only after they reflexively pulled the trigger the moment a target appeared; what they had shot was an elephant resting within its family herd.
Developed over the course of a…
Burch Tree Counseling Center Now Offering EMDR Therapy for PTSD and Trauma
Burch Tree Counseling Center is proud to announce the addition of Eye Movement Desensitization and Reprocessing (EMDR) therapy to its services, providing a powerful tool for individuals struggling with Post-Traumatic Stress Disorder (PTSD) and trauma.
As an evidence-based treatment recognized by organizations such as the American Psychological Association (APA) and the Department of Veterans Affairs (VA), EMDR therapy is designed to help clients process and heal from distressing memories. Unlike traditional…
Post Traumatic Stress Disorder (PTSD) Market Report and Forecast 2024-2032
The post-traumatic stress disorder (PTSD) market size is expected to grow at a CAGR of 5.4 % during the forecast period of 2024-2032 in the major markets, driven by increasing prevalence of post-traumatic stress disorder (PTSD), along with reducing stigma around mental health conditions.
Post Traumatic Stress Disorder (PTSD):
Post Traumatic Stress Disorder (PTSD) is a mental health condition triggered by experiencing or witnessing a terrifying event. Symptoms include flashbacks, nightmares, severe…
PTSD Exhibits Emerging Pipeline with 23 Drug Candidates
The study analysed that the PTSD pipeline comprises of 23 drug candidates, of which one drug candidate is in the Phase III stage of development, two drug candidates are in the Phase II stage of development, seven drug candidates are in the Pre-Clinical stage of development, two drug candidates are in Discovery stage, one drug candidate is in Unknown Clinical stage, one drug candidate is in the Discontinued stage and…
Donald Trump And PTSD: PTSD Is Not A Sign Of Weakness Says June Sitler, Author O …
PTSD can take many forms. When one hears Post Traumatic Stress Disorder (PTSD) the image of a Vietnam Vet comes to mind. However, many people from all walks of life may suffer from this disorder. They are the survivors. They can be people who live in the inner city, those who have suffered the loss of a loved one, survivors of childhood trauma in adulthood, or a man or woman…
